Kommuniké från årsstämma i Acarix AB
Årsstämman 2024 i Acarix AB ("Acarix" eller "Bolaget") hölls idag den 14 maj 2024 varvid aktieägarna fattade följan...
Acarix secures a multi-unit order from major cardiology practice with several offices in Florida
Acarix, a leader in rapid AI and acoustics-based cardiac diagnostics, has announced that the CADScor System is now available at multipl...
Invitation to presentation of Acarix´s first quarter report
Acarix will publish its first quarter results on Tuesday 14 May 2024 at 08.00 am (CEST). A live webcast will be held at 15.00 (CEST) th...
CADScor System is now being utilized by Leading Cardiology Practice in the New York Capital Region
Acarix, a leader in advanced acoustic-based cardiac diagnostics, announces the integration of the CADScor System at Capital Cardiology ...
Proposal by the nomination committee prior to the 2024 annual general meeting of Acarix AB (publ)
The Nomination Committee of Acarix consists of Jan Poulsen (Chairman) representing Life Science Invest Fund 1 among others, Anton Rehns...
Acarix receives order from the first freestanding Emergency Room in the US
Acarix, a leader in advanced acoustic-based cardiac diagnostics, announces the CADScor System has been added to the diagnostic tools av...
KALLELSE TILL ÅRSSTÄMMA I ACARIX AB
Aktieägarna i Acarix AB, org.nr 559009-0667 ("Bolaget"), kallas härmed till årsstämma tisdagen den 14 maj 2024 kl. 10:00 i Ba...
NOTICE OF ANNUAL GENERAL MEETING IN ACARIX AB
The shareholders of Acarix AB, reg. no. 559009-0667 (the "Company"), are hereby invited to the annual general meeting on Tues...
Acarix announces the initiation of the first US-based clinical workflow evaluation study
Acarix, a leader in advanced acoustic-based cardiac diagnostics, announces the initiation of the first US-based clinical study to colle...
Acarix inleder klinisk utvärderingsstudie hos University of California
Acarix, ledande inom avancerad akustikbaserad hjärtdiagnostik, tillkännager idag uppstarten av den första kliniska studien i USA i syft...
Acarix antar ny tillväxtfokuserad affärsmodell och ger en uppdatering av strategiska och finansiella mål
Acarix, ledande aktör inom akustik- och algoritmbaserad hjärtdiagnostik, tillkännager idag införandet av en ny innovativ användarbasera...
Acarix adopts new growth-focused business model and provides outlook update as part of our ongoing strategic review
Acarix, a leader in advanced acoustic- and algorithm-based cardiac diagnostics, announces the adoption of a new innovative usage-based ...